The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.
The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.
复制标题
DOI:
10.1038/sj.bjc.6600466
复制
发表时间:
2002-07-29
影响因子:
8.8
通讯作者:
Milroy, R
中科院分区:
文献类型:
--
作者:
Scott, HR;McMillan, DC;Forrest, LM;Brown, DJF;McArdle, CS;Milroy, R
关键词:
The relationship between the magnitude of systemic inflammatory response and the nutritional/functional parameters in patients with inoperable non-small cell lung cancer were studied. The extent of weight loss, albumin, C-reactive protein, performance status and quality of life was measured in 106 patients with inoperable non-small cell lung cancer (stages III and IV). Survival analysis was performed using the Cox proportional hazard model. The majority of patients were male and almost 80% had elevated circulating C-reactive protein concentrations (>10 mg l−1). On multivariate analysis, age (P=0.012), tumour type (0.002), weight loss (P=0.056), C-reactive protein (P=0.047), Karnofsky performance status (P=0.002) and fatigue (P=0.046) were independent predictors of survival. The patients were grouped according to the magnitude of the C-reactive protein concentrations (⩽10, 11–100 and >100 mg l−1). An increase in the magnitude of the systemic inflammatory response was associated with increased weight loss (P=0.004), reduced albumin concentrations (P=0.001), reduced performance status (P=0.060), increased fatigue (P=0.011) and reduced survival (HR 1.936 95%CI 1.414–2.650, P<0.001). These results indicate that the majority of patients with inoperable non-small cell lung cancer have evidence of a systemic inflammatory response. Furthermore, an increase in the magnitude of the systemic inflammatory response resulted in greater weight loss, poorer performance status, more fatigue and poorer survival. British Journal of Cancer (2002) 87, 264–267. doi:10.1038/sj.bjc.6600466 www.bjcancer.com © 2002 Cancer Research UK
登录
查看更多内容
影响因子:
8.8
作者:
Scott, HR;McMillan, DC;Crilly, A;McArdle, CS;Milroy, R
通讯作者:
Milroy, R
影响因子:
9.6
作者:
MOUNTAIN, CF
通讯作者:
MOUNTAIN, CF
影响因子:
2.9
作者:
O'Gorman, P;McMillan, DC;McArdle, CS
通讯作者:
McArdle, CS
影响因子:
8.8
作者:
Abramovitch, R;Marikovsky, M;Neeman, M
通讯作者:
Neeman, M
影响因子:
5.3
作者:
Scott, HR;McMillan, DC;McArdle, CS
通讯作者:
McArdle, CS